# SIH-26133 — PHASE 9 MASTER PROMPT

# NATIONAL-SCALE INTEROPERABILITY + ABDM/HIE + CONSENT-AWARE CLINICAL EXCHANGE

Repository:

https://github.com/neelshingavi/SIH2026

---

# MISSION

Phase 9 transforms Setu from a secure FHIR-based clinical platform into a genuinely interoperable healthcare coordination platform.

The central objective is:

> A patient should be able to move across facilities while their clinical context, consent, referrals, diagnostics, medications and care plans remain interoperable, traceable and clinically meaningful.

This phase must NOT become a superficial ABDM mock.

Do not create fake QR scanning.

Do not create fake ABHA integration.

Do not create fake Health Information Exchange.

Do not hardcode "ABDM connected" indicators.

Build the architecture using proper adapters and clearly separate:

```text
REAL IMPLEMENTATION
PARTIAL IMPLEMENTATION
SANDBOX / MOCK
NOT IMPLEMENTED
```

The final system must be honest about which layer is real.

---

# PHASE 0 — FORENSIC AUDIT

Before writing code, inspect:

```text
FHIR
Consent
Provenance
AuditEvent
Patient
Practitioner
Organization
Location
ServiceRequest
Task
CarePlan
DiagnosticReport
MedicationRequest
MedicationDispense
RiskAssessment
Encounter
Observation
Sync
Exchange
```

Search globally for:

```text
ABDM
ABHA
HIP
HIU
HIE
consent
consentId
healthId
healthInformation
exchange
bundle
DocumentReference
Binary
Provenance
AuditEvent
```

Also search:

```text
mock
fake
dummy
hardcoded
TODO
FIXME
localhost
random
```

Create:

```text
PHASE_9_PRE_AUDIT.md
```

Classify:

```text
P0 = incorrect clinical/interoperability behavior
P1 = major exchange/security problem
P2 = incomplete interoperability
P3 = engineering quality
```

Do not assume the existing documentation reflects implementation.

---

# PHASE 1 — INTEROPERABILITY ARCHITECTURE

Create:

```text
INTEROPERABILITY_ARCHITECTURE.md
```

Document:

```text
Frontline Flutter
        ↓
Setu Gateway
        ↓
FHIR Server
        ↓
Interoperability Adapter
        ↓
External HIE / ABDM-compatible ecosystem
```

The architecture must clearly separate:

```text
Setu internal clinical workflow
```

from:

```text
external health information exchange
```

Do not couple Flutter directly to external exchange infrastructure.

---

# PHASE 2 — ADAPTER PATTERN

Create a clean interface such as:

```text
HealthExchangeAdapter
```

Conceptually:

```text
createExchangeRequest()
submitInformation()
checkStatus()
receiveInformation()
cancelExchange()
```

The rest of Setu must depend on the interface rather than directly on ABDM-specific APIs.

This allows:

```text
Sandbox adapter
Production adapter
Mock adapter
```

without changing clinical workflow code.

---

# PHASE 3 — EXCHANGE STATE MACHINE

Create an explicit exchange state machine.

Example:

```text
DRAFT
↓
CONSENT_REQUIRED
↓
CONSENT_GRANTED
↓
REQUESTED
↓
SUBMITTED
↓
PROCESSING
↓
AVAILABLE
↓
RETRIEVED
↓
COMPLETED
```

Failure states:

```text
REJECTED
EXPIRED
CANCELLED
FAILED
```

Server must enforce valid transitions.

Never allow arbitrary status manipulation from the client.

---

# PHASE 4 — CONSENT MODEL AUDIT

Deeply inspect the current Consent implementation.

Determine whether consent is:

```text
FHIR Consent
```

or:

```text
custom application state
```

If custom logic exists, migrate the clinical authorization decision to a proper FHIR-compatible Consent representation where appropriate.

---

# PHASE 5 — CONSENT PURPOSE

Consent must identify the purpose of exchange.

Examples:

```text
CARE
REFERRAL
DIAGNOSTICS
MEDICATION
TELECONSULT
CONTINUITY_OF_CARE
```

Do not treat:

```text
"consent = true"
```

as sufficient.

---

# PHASE 6 — CONSENT SCOPE

Support explicit scope.

Conceptually:

```text
Patient:
Jane Doe

Purpose:
Continuity of Care

Permitted:
Observation
Condition
MedicationRequest
DiagnosticReport
CarePlan

Not permitted:
Unrelated historical information
```

The exchange layer must enforce the granted scope.

---

# PHASE 7 — CONSENT TIME BOUNDARIES

Consent should support:

```text
period.start
period.end
```

Expired consent must not authorize exchange.

Test:

```text
before consent
during consent
after consent
```

---

# PHASE 8 — CONSENT REVOCATION

Implement:

```text
GRANTED
↓
REVOKED
```

After revocation:

```text
new exchange request
```

must fail.

Also determine behavior for:

```text
already submitted exchange
already retrieved information
```

and document it.

---

# PHASE 9 — CONSENT AUDIT

Every consent action should create an auditable event.

Examples:

```text
CONSENT_CREATED
CONSENT_GRANTED
CONSENT_REVOKED
CONSENT_EXPIRED
CONSENT_CHECK_FAILED
```

Record:

```text
actor
facility
patient
purpose
timestamp
requestId
```

Do not place PHI in generic logs.

---

# PHASE 10 — PROVENANCE

Every externally exchanged clinical dataset must preserve provenance.

Track:

```text
source organization
source practitioner/system
timestamp
purpose
transformation
```

Use FHIR Provenance appropriately.

The system must answer:

> "Where did this clinical information come from?"

---

# PHASE 11 — DATA LINEAGE

For exchanged resources:

```text
Original resource
↓
selected for exchange
↓
transformed
↓
bundled
↓
submitted
↓
received
↓
stored
```

Create a traceable lineage.

---

# PHASE 12 — FHIR BUNDLE STRATEGY

Design explicit Bundle handling.

Determine when to use:

```text
transaction
batch
document
collection
message
```

Do not blindly create one giant Bundle for everything.

Document why each Bundle type is used.

---

# PHASE 13 — CONTINUITY OF CARE BUNDLE

Create a clinically useful continuity package.

Potential contents:

```text
Patient
Encounter
Observation
Condition
MedicationRequest
MedicationDispense
AllergyIntolerance
CarePlan
RiskAssessment
ServiceRequest
DiagnosticReport
Consent
Provenance
```

Only include resources actually available.

Do not generate empty fake resources.

---

# PHASE 14 — MINIMUM NECESSARY DATA

Do not exchange the entire patient record by default.

Implement a purpose-driven selection mechanism.

Example:

```text
Referral:
Patient
current Encounter
relevant Observation
RiskAssessment
Condition
CarePlan
ServiceRequest
```

while avoiding unrelated historical data.

---

# PHASE 15 — CLINICAL CONTEXT

Every exchange should have a reason.

Example:

```text
Purpose:
Emergency Referral

Clinical Context:
Severe hypertension identified during ANC assessment
```

The system must retain this context without unnecessarily exposing PHI in technical logs.

---

# PHASE 16 — PATIENT IDENTITY

Audit patient identity matching.

Never assume:

```text
same name = same patient
```

Implement a deterministic identity resolution strategy using available identifiers.

Potential matching signals:

```text
ABHA identifier
system identifier
DOB
gender
name
phone
```

Do not silently merge uncertain matches.

---

# PHASE 17 — DUPLICATE IDENTITY WORKFLOW

Create states:

```text
MATCH
POSSIBLE_MATCH
NO_MATCH
CONFLICT
```

For:

```text
POSSIBLE_MATCH
```

require human confirmation.

Never auto-merge uncertain patients.

---

# PHASE 18 — EXTERNAL IDENTIFIER MAPPING

Support mapping between:

```text
Setu Patient ID
external patient identifier
facility identifier
```

Do not replace Setu's internal canonical identity.

---

# PHASE 19 — ORGANIZATION IDENTITY

Create consistent representation of:

```text
Facility
PHC
CHC
District Hospital
Specialist Center
Laboratory
Pharmacy
```

Use FHIR Organization / Location where appropriate.

---

# PHASE 20 — PRACTITIONER IDENTITY

Ensure clinical actions can be associated with:

```text
Practitioner
PractitionerRole
Organization
```

where appropriate.

Avoid using only:

```text
userId
```

for clinical provenance.

---

# PHASE 21 — REFERRAL → EXCHANGE

Connect the existing referral workflow:

```text
Risk identified
↓
ServiceRequest
↓
Task
↓
Consent
↓
Information exchange
↓
Receiving facility
```

The exchange should be triggered by a real clinical workflow.

---

# PHASE 22 — REFERRAL CONTEXT PACKAGE

When a referral is accepted, allow the receiving facility to retrieve the clinically relevant context.

Display:

```text
Reason for referral
Relevant vitals
Risk assessment
Current conditions
Medications
Diagnostics
Care plan
```

All data must come from actual FHIR resources.

---

# PHASE 23 — DIAGNOSTIC EXCHANGE

Support exchange of:

```text
ServiceRequest
Observation
DiagnosticReport
```

Maintain linkage:

```text
ServiceRequest
↓
DiagnosticReport
↓
Observation
```

Do not display a diagnostic result without its source context.

---

# PHASE 24 — MEDICATION EXCHANGE

Maintain distinction:

```text
MedicationRequest
≠
MedicationDispense
```

External exchange must preserve this distinction.

---

# PHASE 25 — CAREPLAN EXCHANGE

When continuity of care requires it, exchange:

```text
CarePlan
Task
ServiceRequest
```

and preserve ownership/status.

---

# PHASE 26 — EMERGENCY EXCHANGE

Emergency referrals must have a fast path.

Example:

```text
EMERGENCY
↓
Consent check
↓
Minimum necessary clinical context
↓
Exchange
↓
Delivery acknowledgement
```

If exchange fails:

```text
do NOT claim delivered
```

Instead:

```text
EXCHANGE_FAILED
```

and trigger an operational alert.

---

# PHASE 27 — EXCHANGE ACKNOWLEDGEMENT

Persist:

```text
submittedAt
acceptedAt
availableAt
retrievedAt
completedAt
```

where available.

---

# PHASE 28 — DELIVERY GUARANTEE

Never display:

```text
"Successfully shared"
```

unless the system has evidence of successful submission/acknowledgement.

Distinguish:

```text
QUEUED
SUBMITTED
ACCEPTED
DELIVERED
RETRIEVED
```

---

# PHASE 29 — OFFLINE EXCHANGE

If the worker is offline:

Create:

```text
EXCHANGE_PENDING
```

locally.

When connectivity returns:

```text
Consent
↓
validation
↓
exchange submission
```

must occur.

---

# PHASE 30 — OFFLINE CONSENT SAFETY

Do not allow stale consent to authorize exchange indefinitely.

The offline client may prepare an exchange, but actual external transmission must revalidate consent when network connectivity returns where required.

---

# PHASE 31 — EXCHANGE IDEMPOTENCY

Every exchange request needs:

```text
exchangeId
idempotencyKey
```

Retries must not create duplicate external submissions.

---

# PHASE 32 — EXCHANGE RETRIES

Retry only:

```text
timeout
temporary 5xx
network failure
```

Do not retry:

```text
consent denied
invalid payload
authorization failure
patient identity conflict
```

---

# PHASE 33 — EXCHANGE DEAD LETTER

Failed exchanges must become visible.

Expose:

```text
exchangeId
patient-safe identifier
failure code
retry count
timestamp
status
```

to authorized operators.

---

# PHASE 34 — EXCHANGE CONFLICT

Handle:

```text
same patient
different external identifiers
different demographic information
```

with explicit conflict states.

Never silently overwrite external identity.

---

# PHASE 35 — FHIR VALIDATION BEFORE EXCHANGE

Before submission:

```text
FHIR validation
reference validation
profile validation
consent validation
identity validation
```

must occur.

Reject invalid packages before sending them externally.

---

# PHASE 36 — EXCHANGE SECURITY

Audit:

```text
authentication
authorization
facility scope
consent scope
TLS
token storage
token expiry
request signing
```

where applicable to the selected integration.

Never expose exchange credentials to Flutter.

---

# PHASE 37 — EXTERNAL TOKEN MANAGEMENT

If the exchange integration requires tokens:

Tokens must remain server-side wherever possible.

Never store:

```text
client secrets
private keys
exchange credentials
```

in Flutter source code.

---

# PHASE 38 — CERTIFICATE / TLS HANDLING

Production integrations must use secure transport.

Do not disable:

```text
certificate verification
TLS validation
```

to make development easier.

If local development requires insecure transport, isolate it explicitly.

---

# PHASE 39 — SANDBOX ADAPTER

If production ABDM/HIE credentials are unavailable:

Implement a sandbox adapter.

The UI must explicitly show:

```text
SANDBOX
```

and documentation must say:

```text
Production exchange credentials not configured.
```

Never pretend sandbox traffic is production traffic.

---

# PHASE 40 — ABDM-SPECIFIC ADAPTER

Where the required APIs are known and legally/configurationally available, create a dedicated adapter layer.

Do not spread ABDM-specific logic throughout:

```text
Flutter
ReferralService
PatientService
FHIRService
```

---

# PHASE 41 — HEALTH INFORMATION USER / PROVIDER SEPARATION

If applicable to the chosen exchange architecture, explicitly model the responsibilities of:

```text
Health Information Provider
Health Information User
Consent Manager / Consent Layer
```

Do not incorrectly collapse all actors into one "ABDM service".

---

# PHASE 42 — EXCHANGE ACTOR AUDIT

For every exchange determine:

```text
Who requested?
Who provided?
Who received?
Who authorized?
For what purpose?
```

This must be auditable.

---

# PHASE 43 — EXCHANGE DASHBOARD

Create:

```text
Interoperability Dashboard
```

showing:

```text
pending exchanges
successful exchanges
failed exchanges
consent failures
identity conflicts
average exchange latency
emergency exchange failures
```

Use actual data.

---

# PHASE 44 — PATIENT EXCHANGE HISTORY

Patient timeline should include:

```text
Information requested
Consent granted
Information shared
Information received
```

but only show appropriate details to authorized users.

---

# PHASE 45 — OPERATOR EXCHANGE VIEW

Authorized administrators can inspect:

```text
exchangeId
status
timestamps
facility
failure reason
retry state
```

without exposing unnecessary clinical information.

---

# PHASE 46 — EXCHANGE FAILURE ALERTING

Generate alerts for:

```text
Emergency exchange failed
Exchange queue growing
Consent failure spike
Identity conflict spike
External system unavailable
```

---

# PHASE 47 — INTEROPERABILITY METRICS

Implement real metrics:

```text
exchange_success_total
exchange_failure_total
exchange_pending_total
exchange_latency
consent_denial_total
identity_conflict_total
emergency_exchange_failure_total
```

---

# PHASE 48 — DATA QUALITY METRICS

Measure:

```text
invalid FHIR resources
missing references
missing identifiers
incomplete demographics
unresolved identity conflicts
```

---

# PHASE 49 — FHIR PROFILE GOVERNANCE

Document:

```text
FHIR version
profiles
extensions
terminologies
coding systems
validation rules
```

Do not invent terminology codes casually.

---

# PHASE 50 — TERMINOLOGY NORMALIZATION

Audit clinical coding.

Identify places where the application currently uses free text for:

```text
diagnosis
clinical severity
medication
observation type
referral reason
facility type
```

Where appropriate, use structured coding.

---

# PHASE 51 — TERMINOLOGY SERVICE BOUNDARY

Create an abstraction:

```text
TerminologyService
```

for:

```text
code validation
display names
mapping
```

Do not hardcode terminology logic into UI widgets.

---

# PHASE 52 — MULTILINGUAL TERMINOLOGY

Clinical codes should remain stable while display labels may be translated.

Example:

```text
code:
X

display:
Severe Hypertension
```

Hindi/Marathi/etc. translation must not change the underlying clinical code.

---

# PHASE 53 — AUDIT EVENT COMPLETENESS

Verify audit coverage for:

```text
patient access
patient creation
clinical assessment
risk classification
referral
consent
exchange
diagnostics
medication
teleconsult
follow-up
```

---

# PHASE 54 — BREAK-GLASS ACCESS

If emergency access is supported, implement an explicit break-glass workflow.

Require:

```text
reason
actor
timestamp
patient
facility
```

Generate high-severity audit event.

Do not make emergency access silently bypass authorization.

---

# PHASE 55 — BREAK-GLASS AUDIT

Every break-glass event should be reviewable by authorized administrators.

---

# PHASE 56 — PRIVACY REVIEW

Audit every external exchange for:

```text
minimum necessary information
consent
purpose limitation
facility authorization
identity accuracy
```

---

# PHASE 57 — NO PHI IN TECHNICAL LOGS

Search again for:

```text
console.log(patient)
logger.info(resource)
print(fhir)
```

Remove or sanitize.

---

# PHASE 58 — EXCHANGE ERROR SANITIZATION

External responses may contain sensitive data.

Never dump external exchange responses into logs.

---

# PHASE 59 — EXCHANGE RATE LIMITING

Protect exchange endpoints from:

```text
enumeration
flooding
duplicate submissions
```

---

# PHASE 60 — PATIENT ENUMERATION PROTECTION

External patient lookup must enforce:

```text
authorization
facility scope
purpose
minimum query information
rate limits
```

---

# PHASE 61 — EXCHANGE PERFORMANCE

Measure:

```text
submission latency
FHIR bundle generation latency
FHIR validation latency
external exchange latency
```

---

# PHASE 62 — LARGE BUNDLE HANDLING

Do not construct enormous in-memory bundles.

Implement appropriate limits.

Reject or paginate unsafe requests.

---

# PHASE 63 — EXCHANGE QUEUE

If external exchange is asynchronous, implement durable queue semantics.

Guarantees:

```text
no silent loss
bounded retries
idempotency
dead-letter handling
observability
```

---

# PHASE 64 — EXCHANGE RECONCILIATION

Periodically reconcile:

```text
Setu exchange state
external exchange state
FHIR resources
```

Detect:

```text
submitted locally but absent externally
accepted externally but marked failed locally
duplicate submissions
stuck exchanges
```

---

# PHASE 65 — EXCHANGE OUTAGE

Simulate:

```text
external system DOWN
```

Expected:

```text
clinical workflow continues safely
exchange enters pending/failed state
operator receives alert
no false success
retry occurs after recovery
```

---

# PHASE 66 — CONSENT REVOCATION TEST

Test:

```text
Consent granted
↓
exchange requested
↓
consent revoked
↓
attempt transmission
```

Expected behavior must be explicit and safe.

---

# PHASE 67 — IDENTITY CONFLICT TEST

Test:

```text
Setu Patient
↓
possible external match
↓
conflicting DOB
```

Expected:

```text
CONFLICT
↓
human review
```

No automatic merge.

---

# PHASE 68 — SECURITY TESTS

Add tests for:

```text
401
403
wrong facility
wrong role
expired consent
revoked consent
patient enumeration
exchange token abuse
duplicate exchange
replay attack
```

---

# PHASE 69 — END-TO-END EXCHANGE TEST

Automate:

```text
Create Patient
↓
ANC assessment
↓
Emergency risk
↓
Referral
↓
Consent
↓
Exchange package
↓
Submission
↓
Acknowledgement
↓
Receiving facility
↓
Clinical review
```

Assert:

```text
FHIR valid
consent valid
audit complete
provenance complete
no duplicate exchange
```

---

# PHASE 70 — JANE DOE INTEROPERABILITY DEMO

Create a flagship demonstration:

```text
REMOTE VILLAGE
↓
ASHA offline
↓
Jane Doe assessed
↓
Severe hypertension
↓
RiskAssessment
↓
Emergency ServiceRequest
↓
Consent
↓
Referral
↓
Connectivity restored
↓
FHIR exchange
↓
District Hospital
↓
Specialist reviews context
↓
Teleconsult
↓
Diagnostic request
↓
Diagnostic result
↓
Medication
↓
Follow-up
```

At every stage show the underlying FHIR resources.

---

# PHASE 71 — FHIR RESOURCE INSPECTION

During the demo, make it possible to show actual FHIR JSON for:

```text
Patient
Encounter
Observation
RiskAssessment
Condition
CarePlan
ServiceRequest
Task
Consent
Provenance
DiagnosticReport
MedicationRequest
MedicationDispense
AuditEvent
```

Do not merely show UI cards.

---

# PHASE 72 — INTEROPERABILITY PROOF

The judge should be able to see:

```text
Clinical UI
      ↓
FHIR resource
      ↓
FHIR server
      ↓
Exchange adapter
      ↓
external/sandbox endpoint
```

This proves Setu is not simply a collection of frontend screens.

---

# PHASE 73 — MOCK DISCLOSURE

If any external integration remains simulated:

Create:

```text
INTEGRATION_STATUS.md
```

Example:

```text
FHIR:
REAL

Offline:
REAL

Sync:
REAL

Authentication:
REAL

Referral:
REAL

Teleconsult:
REAL/SANDBOX

ABDM Exchange:
SANDBOX

Production credentials:
NOT CONFIGURED
```

Be brutally honest.

---

# PHASE 74 — NO FAKE GREEN CHECKMARKS

Search UI for:

```text
Connected
Verified
Shared successfully
ABDM Connected
Exchange complete
```

Ensure every success indicator corresponds to actual backend state.

---

# PHASE 75 — DEMO RESILIENCE

The demo must survive:

```text
network interruption
FHIR restart
external exchange failure
duplicate submission
consent revocation
identity conflict
```

without crashing.

---

# PHASE 76 — DOCUMENTATION

Create:

```text
PHASE_9_FINAL_REPORT.md
INTEROPERABILITY_ARCHITECTURE.md
INTEGRATION_STATUS.md
EXCHANGE_STATE_MACHINE.md
CONSENT_MODEL.md
DATA_LINEAGE.md
```

---

# PHASE 77 — TRACEABILITY

Create:

```text
PHASE_9_TRACEABILITY.md
```

Format:

```text
Requirement
↓
Implementation
↓
File
↓
FHIR Resource
↓
Test
↓
Evidence
↓
Status
```

Use:

```text
VERIFIED
PARTIAL
SANDBOX
UNVERIFIED
NOT IMPLEMENTED
```

---

# PHASE 78 — FINAL TEST GATE

Actually execute:

```text
Flutter:
flutter analyze
flutter test

Backend:
npm run build
npm test
npm run test:e2e

Portal:
npm run lint
npm run build
```

Also run:

```text
FHIR validation
exchange integration tests
consent tests
identity tests
security tests
```

Do not claim PASS without execution evidence.

---

# PHASE 79 — FINAL PRODUCTION ARCHITECTURE

The final architecture should communicate:

```text
                    SETU

       ┌─────────────────────────┐
       │      Frontline App      │
       │ Offline-first Flutter   │
       └────────────┬────────────┘
                    │
                    ▼
       ┌─────────────────────────┐
       │      API Gateway        │
       │ Auth + RBAC + Security  │
       └────────────┬────────────┘
                    │
          ┌─────────┴─────────┐
          ▼                   ▼
   ┌──────────────┐    ┌───────────────┐
   │   FHIR Core  │    │ Exchange Layer│
   │    HAPI FHIR │    │ Consent + HIE │
   └──────────────┘    └───────┬───────┘
                               │
                               ▼
                       External Ecosystem

              ┌─────────────────────────┐
              │ Clinical Intelligence   │
              │ Risk + Care Gaps + SLA  │
              └─────────────────────────┘

              ┌─────────────────────────┐
              │ Observability           │
              │ Audit + Metrics + Alert │
              └─────────────────────────┘
```

---

# PHASE 80 — FINAL JUDGE STORY

The system should demonstrate the following transformation:

### BEFORE SETU

```text
Remote worker
↓
isolated patient data
↓
poor connectivity
↓
manual referral
↓
fragmented records
↓
delayed specialist access
↓
care gap
```

### WITH SETU

```text
Offline clinical capture
↓
deterministic risk identification
↓
human escalation
↓
FHIR-native referral
↓
consent-aware information exchange
↓
specialist receives clinical context
↓
teleconsult
↓
diagnostics
↓
medication
↓
follow-up
↓
care gap closure
↓
complete audit + provenance
```

---

# PHASE 81 — FINAL SYSTEM GUARANTEES

The implementation must be able to defend:

```text
No silent clinical data loss
No unauthorized facility access
No silent patient merges
No exchange without authorization
No false delivery confirmation
No duplicate exchange mutation
No unexplained clinical classification
No untraceable external clinical data
No fake production integration claims
```

---

# PHASE 82 — FINAL COMPLETION REPORT

When finished, return ONLY a concise report containing:

1. Files changed
2. Existing interoperability weaknesses discovered
3. Critical fixes
4. FHIR resources added/modified
5. Consent architecture
6. Exchange architecture
7. Identity resolution architecture
8. Offline exchange behavior
9. Security tests actually executed
10. Integration tests actually executed
11. What is REAL
12. What is SANDBOX
13. What remains UNVERIFIED
14. Remaining P0/P1 risks
15. Production readiness score
16. Exact Jane Doe interoperability demo
17. Recommended Phase 10

DO NOT START PHASE 10.

STOP.
